| 30/01 | Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment |  |
| 26/01 | AstraZeneca's Enhertu approved in EU for breast cancer form | |
| 20/01 | Sankyo's Largest Shareholder Trims Stake in Firm | |
| 2022 | TOP NEWS: AstraZeneca receives host of EU approvals or recommendations | |
| 2022 | IFPMA President and CEO of UCB, Jean-Christophe Tellier welcomes Sunao Manabe, Presiden.. | |
| 2022 | Daiichi and AstraZeneca hail promising breast cancer treatment results | |
| 2022 | CORRECT: AstraZeneca cancer drug shows encouraging results in trial | |
| 2022 | AstraZeneca cancer drug shows encouraging results in phase 1 trial | |
| 2022 | TOP NEWS: AstraZeneca's Enhertu lowers death risk in breast cancer | |
| 2022 | TOP NEWS: AstraZeneca receives three recommendations for EU approval | |
| 2022 | Sankyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, .. | |
| 2022 | Sankyo Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2022, Pa.. | |
| 2022 | Daiichi Sankyo upgrades full-year outlook on strength of Enhertu drug | |
| 2022 | Sankyo Co., Ltd. Revises Consolidated Earnings Guidance for Year Ending March 31, 2023 | |
| 2022 | Japanese stocks pare early gains as Fast Retailing weighs | |
| 2022 | Immunic, Inc. Receives Notice of Allowance for Composition-Of-Matter Patent in the Unit.. | |
| 2022 | Sankyo Co., Ltd. Provides Dividend Guidance for Second Quarter and for Year Ended March.. | |
| 2022 | Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023 | |
| 2022 | Sankyo: Notice concerning Determination of Certain Details of the Issuance of Stock Compe.. | |
| 2022 | Sankyo to Grant Stock Compensation-type Options | |
| 2022 | Sankyo: Notice concerning Issuance of Stock Compensation-type Stock Options (Subscription.. | |
| 2022 | Sankyo Co., Ltd. Provides Dividend Guidance for Second Quarter and for Year Ended March.. | |
| 2022 | Sankyo Co., Ltd. Announces Dividend for the Year Ended March 31, 2022, Payable on June .. | |
| 2022 | Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023 | |
| 2022 | Immunic, Inc. Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-8.. | |
| 2022 | Sankyo Acquires Own Shares for Nearly $6 Million in April | |
| 2022 | Sankyo: Notice concerning Status and Completion of Repurchase of the Company's Own Shares | |
| 2022 | Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 8, 2021. | |
| 2022 | Sankyo Co., Ltd.'s Equity Buyback announced on November 8, 2021, has expired with 3,258.. | |
| 2022 | Sankyo: Notice concerning Status of Repurchase of the Company's Own Shares | |
| 2022 | Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 8, 2021. | |
| 2022 | Sankyo: Notice concerning Status of Repurchase of the Company's Own Shares | |
| 2022 | Sankyo's Attributable Profit Skyrockets 313% in April-December 2021 | |
| 2022 | Sankyo: Presentation on Business Results for the First Nine Months of FY 3/2022 | |
| 2022 | Sankyo: Consolidated Financial Statements for the First Nine Months of FY2022 | |
| 2022 | Sankyo Co., Ltd. Announces Management Changes, Effective April 1, 2022 | |
| 2022 | Sankyo Co., Ltd. Revises Earnings Guidance for the Year Ending March 31, 2022 | |
| 2022 | Sankyo Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2022 | |
| 2022 | Sankyo Acquires Own Shares for $24 Million in January | |
| 2022 | Sankyo: Notice concerning Status of Repurchase of the Company's Own Shares | |
| 2022 | EN DIRECTO DESDE LOS MERCADOS: Iberdrola, BBVA, Apple, BAS.. |  |
| 2022 | Transportation and Logistics Systems, Inc. Announces Executive Changes | |
| 2022 | Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 8, 2021. | |
| 2021 | AstraZeneca's Partner Doses First Patient in Late-Stage Trial of Enhertu in Patients Wi.. | |
| 2021 | Sankyo Eyes Prime Market Listing | |
| 2021 | Sankyo: Notice concerning Application for Selection of Prime Market in New Market Segment.. | |
| 2021 | Sankyo Acquires Own Shares for $23 Million | |
| 2021 | Sankyo: Notice concerning Status of Repurchase of the Company's Own Shares | |
| 2021 | Presentation on Business Results for the First Six Months of FY 3/2022 | |
| 2021 | Notice regarding Repurchase of Own Shares | |
| 2021 | Consolidated Financial Statements for the First Six Months of FY2022 | |
| 2021 | Sankyo Co., Ltd. Provides Year End Dividend Forecast of for the Year Ending March 31, 2.. | |
| 2021 | Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2022 | |
| 2021 | Sankyo Co., Ltd. announces an Equity Buyback for 3,500,000 shares, representing 5.71% f.. | |
| 2021 | Sankyo Co., Ltd. authorizes a Buyback Plan. | |
| 2021 | Tranche Update on Kaga Electronics Co.,Ltd.'s Equity Buyback Plan announced on August 5.. | |
| 2021 | Kaga Electronics Co.,Ltd.'s Equity Buyback announced on August 5, 2021, has expired wit.. | |
| 2021 | Kaga Electronics Co.,Ltd. announces an Equity Buyback for 1,300,000 shares, representin.. | |
| 2021 | Sankyo Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended Ju.. | |
| 2021 | Sankyo Co., Ltd. Provides Dividend Forecast for the Second Quarter and Fourth Quarter o.. | |
| 2021 | Sankyo Co., Ltd. Provides Earnings Forecast for the Year Ending March 31, 2022 | |
| 2021 | Kaga Electronics Co.,Ltd. authorizes a Buyback Plan. | |
| 2021 | Sankyo: Notice concerning Determination of Certain Details of the Issuance of Stock Compe.. | |
| 2021 | Sankyo: Notice concerning Issuance of Stock Compensation-type Stock Options (Subscription.. | |
| 2021 | Sankyo: Notice concerning Personnel Changes | |
| 2021 | Sankyo: Presentation on Business Results of FY 3/2021 | |
| 2021 | Sankyo: Consolidated Financial Statements Results for the fiscal year ended March 31, 202.. | |
| 2021 | Sankyo: Notice concerning Redution of Directors' and Officers' Compensation | |
| 2021 | Sankyo Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2022 | |
| 2021 | Sankyo Co., Ltd. Announces Consolidated and Non-Consolidated Earnings Results for the F.. | |
| 2021 | Sankyo Co., Ltd. Announces Dividend for the Year Ended March 31, 2021, Payable on June .. | |
| 2021 | Sankyo Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year 2022 .. | |
| 2021 | Sankyo: Notice concerning Change of Representative Directors | |
| 2021 | Sankyo: Notice concerning Organizational Changes and Presonnel Changes | |
| 2021 | Sankyo Co., Ltd. Announces the Retirement of Kimihisa Tsutsui as Representative Directo.. | |
| 2021 | Sankyo Co., Ltd. Announces Organizational Changes and Presonnel Changes | |
| 2021 | Daiichi Sankyo : Says Started First Vaccinations In A Phase 1/2 Clinical .. | |
| 2021 | Japan stocks end flat as investors await Fed, BOJ verdicts | |
| 2021 | Daiichi Sankyo to Transfer the Marketing and Distribution Rights to AstraZeneca | |
| 2021 | Sankyo : to Dissolve Subsidiary International Card System | |
| 2021 | Sankyo: Notice concerning Dissolution and Liquidation of a Consolidated Subsidiary | |
| 2021 | Sankyo: Notice concerning Revision of the Forecast of the Financial Results for the Year .. | |
| 2021 | Sankyo: Notice concerning Organizational Changes and Personnel Changes | |
| 2021 | Sankyo Co., Ltd. Announces Organizational Changes | |
| 2021 | Sankyo Co., Ltd. Revises Earnings Guidance for the Year Ending March 31, 2021 | |
| 2021 | Japan shares extend gains to close at 30-yr high on recovery hopes | |
| 2021 | Japan stocks continue to surge on vaccine-fuelled recovery hopes | |
| 2021 | Japan's Nikkei closes above 30,000 on earnings rebound, economy growth hopes | |
| 2021 | Japan's Nikkei closes above 30,000 on earnings rebound, economy growth hopes | |
| 2021 | Japan shares edge higher driven by Honda's upbeat earnings outlook | |
| 2021 | Sankyo : Attributable Profit Plunges 68% in April-December 2020 | |
| 2021 | Sankyo Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended Decemb.. | |
| 2021 | Sankyo Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2021 | |
| 2021 | Sankyo Co., Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2021 | |
| 2021 | Astrazeneca : bekommt EU-Freigabe für neues Brustkrebsmedikament |  |
| 2021 | Japan stocks start year in red as Tokyo braces for state of emergency | |
| 2021 | Japanese shares fall as PM Suga considers state of emergency for Tokyo | |
| 2020 | Japan shares end near three-decade high after Trump signs stimulus bill | |
| 2020 | Japan stocks end higher on gains in drugmakers, tech stocks | |
| 2020 | Nikkei rises as pharma stocks gain on hopes of existing vaccines working on new virus s.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
